Navigation Links
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results

Loss before income

taxes (5,111,194) (6,721,168) (10,433,518) (22,425,359)

Income tax benefit - - 1,291,444 778,308

NET LOSS $(5,111,194) $(6,721,168) $(9,142,074) $(21,647,051)

Basic and diluted

net loss per

common share $(0.06) $(0.09) $(0.11) $(0.30)

Weighted average

number of common

shares outstanding

used in computing

basic and diluted

net loss per common

share 85,204,169 78,052,712 85,195,179 73,329,042


Consolidated Balance Sheets


March 31, June 30,

2008 2007


Current assets:

Cash and cash equivalents $14,223,326 $31,447,615

Available-for-sale investments 3,385,752 2,323,642

Accounts receivable 338,870 607,841

Prepaid expenses and other current assets 707,261 1,008,464

Total current assets 18,655,209 35,387,562

Property and equipment, net 5,478,267 6,070,226

Restricted cash 475,000 475,000

Other assets 58,926 848,446

Total assets $24,867,402 $42,781,234


Current liabilities:

Capital lease obligations and notes

payable, current portion $281,840 $216,841

Accounts payable 979,142 1,120,894

Accrued expenses

SOURCE Palatin Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
2. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
3. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
4. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
5. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Veran Medical Technologies Secures $4.75M in First Institutional Funding
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. InSet Technologies Appoints Jon Tremmel to its Board of Directors
Post Your Comments:
(Date:10/30/2014)... 30, 2014 Spartan Bioscience announced today ... CYP2C19 System . It detects CYP2C19 genetic mutations in ... , The Spartan RX CYP2C19 System is the first ... approved in Canada. Due to the system’s ease of ... used by healthcare professionals such as doctors, nurses, pharmacists, ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and ... its fleet of high volume High Pressure Processing (HPP) systems. ... return to PackExpo this year, which is where we first ... Jeff Williams, CEO at Avure. “Sales of the new Avure ... meeting the challenges of market demand for higher throughput. We ...
(Date:10/30/2014)... 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... will present a company overview at the Nomura Biotechnology Conference ... Boston, MA. A live ... & Media" section of the Company,s website, .  ... 48 hours and will be archived for a limited time. ...
(Date:10/30/2014)...  Regado Biosciences, Inc. (Nasdaq: RGDO ), ... and live audio webcast on Thursday, November 6, 2014, ... 2014 financial results. Interested participants and investors ... for domestic callers or (412) 902-4276 for international callers. ... investor relations section of the Regado website at ...
Breaking Biology Technology:Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... siRNA expression construct into a variety of mammalian cells ... , ... Modified CMV promoter efficiently expresses hairpin siRNAs , ... , Efficient delivery of siRNA or an siRNA , ...
... In the past few years, interest in the , ... small RNA molecules has , ... interrelated lines of research. In one, small double-stranded , ... (siRNAs) have been , ...
... Dicer and Escherichia coli RNase III can be used ... cleave long dsRNA, producing siRNA cocktails that are , ... endoribonuclease that contains RNase III domains and is the , ... of long dsRNAs to siRNA in the , ...
Cached Biology Technology:Delivering siRNA Using Adenoviral Vectors 2Delivering siRNA Using Adenoviral Vectors 3Delivering siRNA Using Adenoviral Vectors 4Detecting miRNA & siRNA 2Detecting miRNA & siRNA 3Detecting miRNA & siRNA 4Detecting miRNA & siRNA 5Detecting miRNA & siRNA 6Detecting miRNA & siRNA 7Detecting miRNA & siRNA 8Detecting miRNA & siRNA 9Dicer vs. RNase III for Preparation of siRNA Cocktails 2Dicer vs. RNase III for Preparation of siRNA Cocktails 3
(Date:10/29/2014)... food, but they also need protection from its harmful rays, ... molecules in plants that shields them from sun damage. Now, ... Chemical Society , one team reports on the mechanics of ... colleagues at Purdue University note that the harsh ultraviolet radiation ... plant DNA and, as a result, hinder plant growth. ...
(Date:10/29/2014)... nanoparticles is all the rage. Thousands of scientists worldwide ... of whether titanium dioxide nanoparticles from sun creams can ... carbon nanotubes from electronic products are as hazardous for ... nanoparticles in food can get into the blood via ... research funds are flowing – and the number of ...
(Date:10/29/2014)... – As bodies decompose, their types and numbers ... they provide could mean the difference between a ... State University is using a more than $866,000 ... death-scene investigators examine these changing populations. The microbial ... location of death, gender, race, socioeconomic relations and ...
Breaking Biology News(10 mins):Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3MSU partners with Detroit to investigate death scenes 2
... 2010 - Novocure reported today that patients with advanced ... in survival time when tumor treating fields (TTF) therapy ... outcomes for patients receiving chemotherapy alone. Dr. Miklos Pless, ... center in Switzerland, presented the data at the European ...
... have reported direct evidence that taking up smoking results in ... results were reported at the 35th Congress of the European ... link between smoking and cancer has been established for decades, ... Institute of Cancer Studies, Birmingham, who presented the results. Smoking ...
... at Chicago College of Medicine have found how gene expression ... unusual types of breast tumors. Their findings may offer new ... 8 issue of the Journal of Biological Chemistry, ... Approximately 70 percent of breast cancers express the estrogen receptor. ...
Cached Biology News:Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer 2Study reveals cancer-linked epigenetic effects of smoking 2Clue to unusual drug-resistant breast cancers found 2
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection reagents ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Biology Products: